Cagrilintide — Research Overview

Also known as: CagriSema

A long-acting amylin analog studied for its effects on appetite regulation, satiety signaling, and metabolic markers. Targets amylin receptors in the hypothalamus, producing complementary appetite-suppressive effects to GLP-1 agonists. Under investigation in combination with semaglutide (CagriSema) for synergistic weight-loss benefits.

Back to Peptide Encyclopedia